Articles: 166
(average impact: 4.6); Book chapters: 19: Citations:
7,531 (by June 2025).
(Last update: 2025, click here
for full list).
Selected Articles Five selected articles from the last 2 years (average impact: 5.45).
Nuñez FF, Siqueiros-Marquez L, Adan-Castro E, Zamora M, Robles JP, Ruíz-Herrera X, Bertsch T, Triebel J, Martínez de la Escalera G, Clapp C.Vasoinhibin is generated by the renin-angiotensin system. Endocrinology 166, bqaf023, 2025. doi: 10.1210/endocr/bqaf023. FI: 5.054
Adan-Castro E, Zamora M, Granados-Carrasco D, Siqueiros-Márquez L, García-Rodrigo JF, Bertsch T, Triebel J, Martínez de la Escalera G, Robles JP, Clapp C. Topical eye administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema. Scientific Reports, In press. 2025. FI: 3.800
Núñez-Amaro CD, López M, Adán-Castro E, Robles-Osorio ML, García-Franco L, García-Roa M, Villalpando-Robles Y, Ramírez-Neria P, Pineiro N, Rubio-Mijangos JF, Sánchez J, Ramírez-Hernández G, Siqueiros-Márquez L, Díaz-Lezama N, López-Star E, Bertsch T, Martínez de la Escalera G, Triebel J, Clapp C. Levosulpiride for the treatment of diabetic macular oedema: A phase 2 randomized clinical trial. EYE, 2023. doi: 10.1038/s41433-023-02715-5. FI: 4.456
García-Rodrigo JF, Ortíz-Arballo G, Martínez-Díaz OF, Furuzawa-Carballeda J, Ruíz-Herrera X, Macías F, Ledesma-Colunga MG, Martínez de la Escalera G, Clapp C. Prolactin inhibits or stimulates the inflammatory response of joint tissues in a cytokine-dependent manner. Endocrinology 164:1-14, doi: 10.1210/endocr/bqad156, 2023. FI: 5.045
Robles JP, Zamora M, Siqueiros-Marquez L, Adan-Castro E, Ramirez-Hernadez G, Nuñez FF, Lopez-Casillas F, Millar RP, Bertsch T, Martínez de la Escalera G, Tiebel J, Clapp C. The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide. Angiogenesis 25:57-70, 2022. doi: 10.1210/endocr/bqad156, 2023. FI: 9.78
